Surgery Partners, Inc. (SGRY) Tops Q3 EPS by 5c; Offers FY23 Revenue Guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.05 better than the analyst estimate of $0.14. Revenue for the quarter came in at $674.1 million versus the consensus estimate of $671.99 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2023 revenue of $2.75 billion, versus the consensus of $2.76 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings